Cholecystokinin-producing (I) cells of intestinal mucosa in dexamethasone-treated rats

Regul Pept. 2011 Nov 10;171(1-3):6-10. doi: 10.1016/j.regpep.2011.05.012. Epub 2011 Jun 25.

Abstract

The aim of this study was to investigate the morphological, immunohistochemical and ultrastructural changes of cholecystokinin-producing (I) cells of gastrointestinal mucosa in dexamethasone-treated rats (D). After 12-daily intraperitoneal administration of 2mg/kg dexamethasone, rats developed diabetes similar to human diabetes mellitus type 2. The mean diameter of the duodenum was significantly decreased due to significant reduction of volume fraction and profile area of lamina propria. There was a decrease in volume fraction and number of cholecystokinin (CCK)-producing cells per mm(2) of mucosa, as well as their numerical density, but without statistical significance. Also, dexamethasone induced appearance of hyperactive duodenal I-cells with small number of granules and dilated endoplasmic reticulum. In conclusion, the present study showed that morphological changes in duodenum cholecystokinin-producing (I) cells occurred in diabetic rats, in a manner which, suggests compensatory effort of CCK cells in diabetic condition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cholecystokinin / metabolism*
  • Dexamethasone / pharmacology
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / pathology*
  • Diabetes Mellitus, Type 2 / chemically induced
  • Diabetes Mellitus, Type 2 / pathology*
  • Duodenum / drug effects
  • Duodenum / pathology*
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / pathology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology*
  • Male
  • Prediabetic State / chemically induced
  • Prediabetic State / pathology*
  • Rats
  • Rats, Wistar

Substances

  • Dexamethasone
  • Cholecystokinin